Stay updated on Savolitinib Combo in EGFRm+ NSCLC Clinical Trial
Sign up to get notified when there's something new on the Savolitinib Combo in EGFRm+ NSCLC Clinical Trial page.

Latest updates to the Savolitinib Combo in EGFRm+ NSCLC Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedA new page revision tag 'Revision: v3.5.4' was added and the previous 'Revision: v3.5.3' tag was removed, signaling a version update of the page without altering the study details.SummaryDifference0.0%

- Check27 days agoChange DetectedThe Taiwan site entry with postal code 333 was updated to Taoyuan City, Taiwan, 333. The previous Taoyuan, Taiwan, 333 entry was removed and replaced with the Taoyuan City variant to reflect the corrected city designation.SummaryDifference0.0%

- Check42 days agoChange DetectedThe page’s displayed revision/version number was incremented from **v3.5.2** to **v3.5.3**.SummaryDifference0.0%

- Check49 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check78 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check85 days agoChange DetectedAdded Revision: v3.4.3 and deleted Revision: v3.4.2 in the page’s version history. This is a minor update that does not modify the study content or results.SummaryDifference0.1%

Stay in the know with updates to Savolitinib Combo in EGFRm+ NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Savolitinib Combo in EGFRm+ NSCLC Clinical Trial page.